2m 2m 2m 2m 2m 2m 2m
Eli Lilly & Co (LLY)
NYSE
$1,096.32-$5.76 (-0.52%)
Price as of Jun 23, 2026 12:15 PM EDT- $982.8BMarket Cap
- 44.02%1-Year Change
- Drug Manufacturers - GeneralIndustry
Eli Lilly & Co (LLY)
$1,096.32-$5.76 (-0.52%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 65.2B +44.70% | 45.0B +32.00% | 34.1B +19.56% | 28.5B +0.79% | |
Cost of Revenue | 11.1B +31.29% | 8.4B +18.87% | 7.1B +6.82% | 6.6B -9.34% | |
Gross Profit | 54.1B +47.79% | 36.6B +35.44% | 27.0B +23.41% | 21.9B +4.31% | |
Sales and Marketing Expense | 11.1B +29.09% | 8.6B +16.08% | 7.4B +14.95% | 6.4B +0.14% | |
Research and Development Expense | -13.3B +21.35% | -11.0B +18.01% | -9.3B -229.52% | 7.2B +2.35% | |
Depreciation and Amortization Expense | 2.0B +13.04% | 1.8B +15.67% | 1.5B +0.32% | 1.5B -1.62% | |
Total Operating Expenses | 11.1B +31.29% | 8.4B +18.87% | 7.1B +6.82% | 6.6B -9.34% | |
Operating Profit | 25.7B +102.92% | 12.7B +93.46% | 6.6B -3.70% | 6.8B +10.57% | |
Interest Income | N/A N/A | -49.8M +111.91% | -23.5M -94.40% | -420.0M -335.96% | |
Interest Expense | N/A N/A | N/A N/A | -485.9M +46.53% | -331.6M -2.41% | |
Interest Income and Expense and Net | 0 +100.00% | -49.8M -90.22% | -509.4M -911.15% | 62.8M +147.24% | |
Total Nonoperating Income and Expense | -571.0M +161.21% | -218.6M -326.06% | 96.7M +130.13% | -320.9M +59.18% | |
Income before Taxes | 25.7B +102.92% | 12.7B +93.46% | 6.6B -3.70% | 6.8B +10.57% | |
Income Taxes | 5.1B +143.54% | 2.1B +59.06% | 1.3B +134.01% | 561.6M -2.13% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 20.6B +94.90% | 10.6B +102.08% | 5.2B -16.08% | 6.2B +11.88% | |
Net Income from Continuing Operations Applicable to Common | 25.7B +102.92% | 12.7B +93.46% | 6.6B -3.70% | 6.8B +10.57% | |
Basic EPS and Net Income | 23.00 +95.58% | 11.76 +102.06% | 5.82 -16.02% | 6.93 +12.68% | |
Diluted EPS and Net Income | 22.95 +95.99% | 11.71 +101.90% | 5.80 -15.94% | 6.90 +12.75% | |
Basic Weighted Average Shares | 897.3M -0.37% | 900.6M +0.05% | 900.2M -0.17% | 901.7M -0.58% | |
Diluted Weighted Average Shares | 899.3M -0.53% | 904.1M +0.09% | 903.3M -0.15% | 904.6M -0.77% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 7.3B +122.37% | 3.3B +15.96% | 2.8B +36.36% | 2.1B -45.87% | |
Short-Term Investments | 16.0M -89.66% | 154.8M +41.89% | 109.1M -24.65% | 144.8M +60.71% | |
Cash and Cash Equivalents and Short-Term Investments | 7.3B +112.78% | 3.4B +16.92% | 2.9B +32.37% | 2.2B -43.41% | |
Total Current Assets | 55.6B +69.91% | 32.7B +27.26% | 25.7B +42.65% | 18.0B -2.26% | |
Accumulated Depreciation | 12.6B +6.54% | 11.8B +6.21% | 11.1B +8.46% | 10.2B +2.57% | |
Property and Plant and Equipment and Net | 24.7B +44.28% | 17.1B +32.44% | 12.9B +27.30% | 10.1B +12.90% | |
Total Long-Term Assets | 7.0B +22.24% | 5.7B +14.63% | 5.0B -50.81% | 10.1B +12.90% | |
Total Assets | 112.5B +42.89% | 78.7B +22.98% | 64.0B +29.33% | 49.5B +1.40% | |
Income Taxes Payable | 5.9B +44.67% | 4.1B +5.50% | 3.8B -9.90% | 4.3B -26.10% | |
Total Short-Term Debt | 1.6B -68.05% | 5.1B -25.89% | 6.9B +359.96% | 1.5B -2.42% | |
Total Current Liabilities | 35.2B +24.14% | 28.4B +3.97% | 27.3B +59.25% | 17.1B +13.85% | |
Total Long-Term Debt | 40.9B +43.26% | 28.5B +55.71% | 18.3B +24.31% | 14.7B -3.97% | |
Total Long-Term Liabilities | 50.7B +40.61% | 36.1B +39.53% | 25.8B +19.81% | 21.6B -12.29% | |
Total Liabilities | 35.2B +24.14% | 28.4B +3.97% | 27.3B +59.25% | 17.1B +13.85% | |
Retained Earnings | 24.5B +80.66% | 13.5B +31.35% | 10.3B +2.69% | 10.0B +12.10% | |
Total Stockholders Equity | 26.5B +86.97% | 14.2B +31.75% | 10.8B +1.15% | 10.6B +18.61% | |
Total Shares Outstanding | 944.8M -0.33% | 947.9M -0.20% | 949.8M -0.09% | 950.6M +99,534.85% | |
Cash Flow | |||||
Cash from Operating Activities | 16.8B +90.67% | 8.8B +107.96% | 4.2B -40.15% | 7.1B -2.43% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -11.0B +17.96% | -9.3B +30.04% | -7.2B +119.30% | -3.3B +18.08% | |
Dividends Paid | 5.4B +15.03% | 4.7B +15.02% | 4.1B +15.09% | 3.5B +14.55% | |
Cash from Financing Activities | -2.2B -279.90% | 1.2B -64.81% | 3.5B +164.65% | -5.4B +30.87% | |
Financials Ratio | |||||
Gross Margin | 83.04% +2.13% | 81.31% +2.61% | 79.25% +3.22% | 76.77% +3.50% | |
Operating Margin | 39.48% +40.23% | 28.15% +46.56% | 19.21% -19.45% | 23.85% +9.71% | |
Return on Assets | 21.59% +45.49% | 14.84% +60.70% | 9.23% -27.32% | 12.71% +8.63% | |
Return on Equity | 101.36% +19.47% | 84.84% +73.41% | 48.93% -23.11% | 63.63% -16.67% | |
Revenue Growth | 44.70% +39.72% | 32.00% +63.58% | 19.56% +2,383.81% | 0.79% -94.89% | |
Current Ratio | 1.58 +36.86% | 1.15 +22.41% | 0.94 -10.42% | 1.05 -14.16% | |
Cash Ratio | 0.21 +79.08% | 0.12 +11.52% | 0.10 -14.34% | 0.12 -52.46% | |
Debt-to-Equity Ratio | 1.60 -32.43% | 2.37 +1.23% | 2.34 +53.58% | 1.52 -18.91% | |
Debt-to-Assets Ratio | 0.38 -11.58% | 0.43 +8.45% | 0.39 +20.12% | 0.33 -5.17% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow